🇺🇸 FDA

Intelligence · Patent portfolio

Regeneron Ireland Designated Patents

Full USPTO pharma patent portfolio for Regeneron Ireland Designated — grant dates, expiration, and drug cross-links.

Patents
8,292
Expiring ≤24m
426

Quick answer

Regeneron Ireland Designated has 8,292 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 426 expire within 24 months — use filters for patent-cliff planning.

Page 173 of 173

  1. US 6028171

    Class I MHC modulation of surface receptor activity

    Expires Mon Feb 17 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  2. US 6028106

    Treatment of urinary incontinence with nitric oxide synthase substrates and/or nitric oxide donors alone or in combination with estrogen or progesterone and/or other agents

    Expires Mon Feb 17 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  3. US 6025369

    N-methyl-D-aspartate (NMDA) receptor blockers for the prevention of atherosclerosis

    Expires Mon Feb 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  4. US 6024936

    Antibody-based method of localizing activated thrombin receptors

    Expires Mon Feb 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  5. US 6025150

    Methods and compositions for wound healing

    Expires Mon Feb 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  6. US 6025328

    Antitumor agents

    Expires Mon Feb 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  7. US 6025176

    Cloning and expression of human islet glutamic acid decarboxylase autoantigen

    Expires Mon Feb 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  8. US 6022697

    Methods for the diagnosis and treatment of insulin-dependent diabetes mellitus

    Expires Mon Feb 03 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  9. US 6022854

    Platelet specific therapeutic compound and method of treating

    Expires Mon Feb 03 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  10. US 6022521

    Method of establishing the optimal radiation dose for radiopharmaceutical treatment of disease

    Expires Mon Feb 03 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  11. US 6022736

    Nucleic acid vectors comprising DNase I hypersensitive sites

    Expires Mon Feb 03 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  12. US 6020154

    H. influenzae HxuB and HxuC genes, proteins and methods of use

    Expires Mon Jan 27 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  13. US 6020197

    Method for production of neuroblasts

    Expires Mon Jan 27 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  14. US 6017882

    Modified vitamin K-dependent polypeptides

    Expires Mon Jan 20 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  15. US 6017524

    Inhibiting the growth p53 deficient tumor cells by administering the p53 gene

    Expires Mon Jan 20 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  16. US 6017962

    Method of depletion of methionine in plasma and solid tumors and uses thereof

    Expires Mon Jan 20 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  17. US 6017714

    Netrins

    Expires Mon Jan 20 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  18. US 6017960

    Method of treating post-inflammatory hyperpigmentation in black skin with a retinoid, and method of lightening black skin with a retinoid

    Expires Mon Jan 20 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  19. US 6015659

    Inducement of thermotolerance with benzoquinonoid ansamycins

    Expires Mon Jan 13 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  20. US 6015665

    Method and composition for regulating apoptosis

    Expires Mon Jan 13 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  21. US 6015832

    Methods of inactivating bacteria including bacterial spores

    Expires Mon Jan 13 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  22. US 6015811

    Antitumor Chrysene derivatives

    Expires Mon Jan 13 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  23. US 6015882

    Vaccines, antibodies, proteins, glycoproteins, DNAs and RNAs for prophylaxis and treatment of Cryptosporidium parvum infections

    Expires Mon Jan 13 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  24. US 6015660

    Borna disease viral sequences, diagnostics and therapeutics for nervous system diseases

    Expires Mon Jan 13 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  25. US 6015542

    Radioimmunotherapy of lymphoma using anti-CD20 antibodies

    Expires Mon Jan 13 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  26. US 6015599

    High vertical aspect ratio thin film structures

    Expires Mon Jan 13 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  27. US 6013781

    Semaphorin gene family

    Expires Mon Jan 06 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  28. US 6013785

    Polynucleoside chain having multiple ribonucleosides, the nucleosides coupled by guanidyl linkages

    Expires Mon Jan 06 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  29. US 6013521

    Method for production of neuroblasts

    Expires Mon Jan 06 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  30. US 6013628

    Method for treating conditions of the eye using polypeptides

    Expires Mon Jan 06 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  31. US 6010908

    Gene therapy by small fragment homologous replacement

    Expires Mon Dec 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  32. US 6010691

    Methods for enhancing permeation of a topically administered physiologically active substance

    Expires Mon Dec 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  33. US 6010846

    Methods for measuring cellular proliferation and destruction rates in vitro and in vivo

    Expires Mon Dec 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  34. US 6011139

    Hybridomas and monoclonal antibodies that specifically bind to glutamic acid decarboxylase peptides

    Expires Mon Dec 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  35. US 6011055

    Treatment of cystic disease with compounds which stimulate TNF-.alpha. production in vivo

    Expires Mon Dec 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  36. US 6010876

    Clavanins

    Expires Mon Dec 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

How many patents does Regeneron Ireland Designated have?

8,292 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Regeneron Ireland Designated patents expire?

426 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.